Related Funds
Fund Name | Location |
A+E Networks | New York, New York, United States |
Aipu Yiyao Touzi | China, Fujian, Hunan |
Barwell Plc | - |
Good People Ventures | California, Santa Clarita, United States |
Hatch Ventures | British Columbia, Canada, Vancouver |
Hsu Gamma Investment | Florida, Miami, United States |
Huiyu Capital | - |
Huizhoushi Hairong Keji | China, Guangdong, Huizhou |
Kalpathi Investments | Chennai, India, Tamil Nadu |
Lanta Capital Holdings | HaMerkaz, Hod Hasharon, Israel |
Mid Europa Partners | England, London, United Kingdom |
Mission Bay Capital | California, San Francisco, United States |
Numis Securities | England, London, United Kingdom |
Primus Capital | Budapest, Hungary |
Queen City Angels | - |
Spruce Capital Partners | California, San Francisco, United States |
VisVires Capital | France, Ile-de-France, Paris |
Vocap Ventures | Atlanta, Georgia, United States |
WILO | Dortmund, Germany, Nordrhein-Westfalen |
Yuanxi Capital | China, Guangdong, Shenzhen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
IASO Biotherapeutics | $77M | 17 Jan 2023 | Xuanwu District, Jiangsu, China | ||
Beilai Bio | $46M | 15 Apr 2022 | Irvine, California, United States | ||
Matrixtime Robotics | $15M | 18 Aug 2020 | Minhang District, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
IASO Biotherapeutics | $77M | 17 Jan 2023 | Xuanwu District, Jiangsu, China | ||
Beilai Bio | $46M | 15 Apr 2022 | Irvine, California, United States | ||
Matrixtime Robotics | $15M | 18 Aug 2020 | Minhang District, China |